Half of elderly patients routinely treated for colorectal cancer receive a sub-standard treatment

被引:74
作者
Aparicio, Thomas [1 ]
Navazesh, Atika [1 ]
Boutron, Isabelle [2 ]
Bouarioua, Nadia [1 ]
Chosidow, Denis [3 ]
Mion, Mathieu [4 ]
Choudat, Laurence [5 ]
Sobhani, Iradj [1 ]
Mentre, France [2 ]
Soule, Jean Claude [1 ]
机构
[1] Univ Paris 07, Hop Bichat, AP HP, Serv Hepatogastroenterol,UFR Med, Paris, France
[2] Univ Paris 07, Hop Bichat, AP HP, Dept Epidemiol Biostat & Rech Clin,UFR Med, Paris, France
[3] Univ Paris 07, Hop Bichat, AP HP, Serv Chirurg Digest,UFR Med, Paris, France
[4] Univ Paris 07, Hop Bichat, AP HP, Serv Geriatrie,UFR Med, Paris, France
[5] Univ Paris 07, Hop Bichat, AP HP, Serv Anatomopathol,UFR Med, Paris, France
关键词
Colon cancer; Rectal cancer; Elderly; Prognostic factor; DEFINED FRENCH POPULATION; III COLON-CANCER; ADJUVANT-CHEMOTHERAPY; POOLED ANALYSIS; RECTAL-CANCER; SURVIVAL; AGE; FLUOROURACIL; DIAGNOSIS; OLDER;
D O I
10.1016/j.critrevonc.2008.11.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Several database studies report a lack of care in elderly patients with colorectal cancer. Purpose: To describe the management of elderly patients admitted for colorectal cancer; to identify factors associated with standard management according to recommendations and to study factors influencing the survival. Patients and methods: All consecutive patients over 75 years managed for a colorectal adenocarcinoma in our hospital from 1995 to 2000 and followed until 2006 were retrospectively included. The appropriateness of the management of their disease according to the recommendations available at that time was assessed. Several risk factors in receiving the standard cancer treatment were tested using univariate and then multivariate logistic regression. Risk factors of survival were studied using univariate and then multivariate survival analysis. Results: One hundred and ten patients were included. Median age was 82 years (range: 75-96). A surgical treatment was performed in 96 patients. The median overall survival was 32 (1-108) months. A standard cancer treatment according to recommendations was performed in 53 (48%) patients: adjuvant chemotherapy in 6/23 patients with stage III tumour, palliative chemotherapy in 3/18 patients with stage IV tumour and adjuvant radiotherapy in 4/14 patients who had a rectal tumour resection. Multivariate analysis retains tumour stage I or II (OR = 7.6, 95% C.I. = [2.9-19.9], p < 0.0001) as the only factor associated with standard treatment and presence of metastasis (HR = 3.9, 95% C.I. [1.4-10.8], p = 0.005), and Charlson's score >3 (HR = 28.9, 95% C.I. [2.5-335.6], p = 0.001) as independent risk factors of poor survival. Conclusions: Fifty two percent of elderly patients have had a sub-standard cancer treatment. The majority had a surgical treatment, but only a few received chemotherapy or radiotherapy. Metastasis, older age and Charlson's comorbidity score are the main prognosis factors of poor survival. (c) 2008 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:249 / 257
页数:9
相关论文
共 35 条
[1]  
[Anonymous], 2000, LANCET, V356, P968
[2]  
[Anonymous], 1995, LETT CANCEROLOGUE, VIV, P12
[3]   Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly [J].
Aparicio, T ;
Desramé, J ;
Lecomte, T ;
Mitry, E ;
Belloc, J ;
Etienney, I ;
Montembault, S ;
Vayre, L ;
Locher, C ;
Ezenfis, J ;
Artru, P ;
Mabro, M ;
Dominguez, S .
BRITISH JOURNAL OF CANCER, 2003, 89 (08) :1439-1444
[4]   Colonoscopy in patients 80 years of age and older is safe, with high success rate and diagnostic yield [J].
Arora, A ;
Singh, P .
GASTROINTESTINAL ENDOSCOPY, 2004, 60 (03) :408-413
[5]   Colon cancer in the elderly: evidence for major improvements in health care and survival [J].
Arveux, I ;
Boutron, MC ;
ElMrini, T ;
Arveux, P ;
Liabeuf, A ;
Pfitzenmeyer, P ;
Faivre, J .
BRITISH JOURNAL OF CANCER, 1997, 76 (07) :963-967
[6]   Trends in the management and survival of digestive tract cancers among patients aged over 80 years [J].
Bouvier, AM ;
Launoy, G ;
Lepage, C ;
Faivre, J .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 22 (03) :233-241
[7]   Estimates of cancer incidence and mortality in Europe in 1995 [J].
Bray, F ;
Sankila, R ;
Ferlay, J ;
Parkin, DM .
EUROPEAN JOURNAL OF CANCER, 2002, 38 (01) :99-166
[8]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[9]   Assessment of outcomes after colorectal cancer resection in the elderly as a rationale for screening and early detection [J].
Clark, AJ ;
Stockton, D ;
Elder, A ;
Wilson, RG ;
Dunlop, MG .
BRITISH JOURNAL OF SURGERY, 2004, 91 (10) :1345-1351
[10]   Capecitabine plus oxaliplatin for the first-line treatment of elderly patients with metastatic colorectal carcinoma - Final results of the southern Italy cooperative oncology group trial 0108 [J].
Comella, P ;
Natale, D ;
Farris, A ;
Gambardella, A ;
Maiorino, L ;
Massidda, B ;
Casaretti, R ;
Tafuto, S ;
Lorusso, V ;
Leo, S ;
Cannone, M .
CANCER, 2005, 104 (02) :282-289